Breast cancer risk rises with age, and outcomes track how early cancers are found. Women have a lifetime breast cancer risk of 12.0%, yet the median diagnosis age is 62 years. With screening mammography recommended for women aged 50 to 74 every 2 years, and individualized decisions for women aged 40 to 49, diagnosis timing strongly influences survival.
Key Takeaways
- 1 in 8 women in the United States will develop breast cancer over the course of her lifetime
- 1 in 656 men in the United States will develop breast cancer over the course of their lifetime
- 51% of women with breast cancer are diagnosed at age 65 years or older
- 28.6% of breast cancer cases are diagnosed in women aged 65 and older
- 30.3% of breast cancer cases are diagnosed in women aged 50–64
- 10.0% of breast cancer cases are diagnosed in women aged 40–49
- 66% of breast cancer cases are estrogen receptor-positive
- 13% of breast cancers are HER2-positive (overexpressed or amplified)
- 72% of breast cancers are diagnosed as localized, regional, or distant with hormone receptor status affecting patterns by age
- About 14% of breast cancer cases are diagnosed at age 50 or younger
- The U.S. Preventive Services Task Force recommends screening mammography every 2 years for women aged 50 to 74 (B recommendation, with grade dependent on interval)
- Women aged 40 to 49 are recommended to make an individual decision about screening mammography (C recommendation)
- The lifetime risk of breast cancer is 12.0% for women
- The lifetime risk of dying from breast cancer is 2.8% for women
- From 2010 to 2020, the number of breast cancer survivors in the United States increased from 2.9 million to 3.8 million
Breast cancer risk and diagnoses rise with age, with most cases found after 50.
Related reading
01 · Category
Epidemiology30 stats
01
1 in 8 women in the United States will develop breast cancer over the course of her lifetime
02
1 in 656 men in the United States will develop breast cancer over the course of their lifetime
03
51% of women with breast cancer are diagnosed at age 65 years or older
04
37% of women with breast cancer are diagnosed between ages 50 and 64
05
6% of women with breast cancer are diagnosed between ages 40 and 49
06
3% of women with breast cancer are diagnosed between ages 30 and 39
07
17% of breast cancer cases are diagnosed at age 50 or younger
08
0.5% of women with breast cancer are diagnosed at age younger than 20
09
The median age at diagnosis for breast cancer is 62 years
10
The median age for diagnosis of ductal carcinoma in situ (DCIS) is 61 years
11
The median age for diagnosis of invasive breast cancer is 62 years
12
A higher lifetime risk of breast cancer is observed with increasing age, rising from 0.06% at age 20 to 0.27% at age 30, 0.90% at age 40, and 2.09% at age 50 (per year)
13
The lifetime probability (risk) of developing breast cancer is 12.0% for women
14
The lifetime probability (risk) of dying from breast cancer is 2.8% for women
15
Risk of breast cancer increases with age, with incidence highest in women aged 70 years and older
16
In SEER, 8.3% of breast cancers occur before age 40
17
In SEER, 9.9% of breast cancers occur between ages 40 and 49
18
In SEER, 34.1% of breast cancers occur between ages 50 and 64
19
In SEER, 47.7% of breast cancers occur at age 65 years or older
20
In SEER, 0.1% of breast cancers occur at age 20 to 29
21
In SEER, 0.6% of breast cancers occur at age 30 to 39
22
In SEER, 0.2% of breast cancers occur at age 10 to 19
23
In SEER, 0.0% of breast cancers occur at age under 10
24
Age-standardized incidence rates for breast cancer increased slightly from 2003 to 2013 among women aged 20–49 years
25
Age-standardized incidence rates for breast cancer increased slightly from 2003 to 2013 among women aged 50–64 years
26
Age-standardized incidence rates for breast cancer increased slightly from 2003 to 2013 among women aged 65–74 years
27
Age-standardized incidence rates for breast cancer increased slightly from 2003 to 2013 among women aged 75 years and older
28
For women aged 40–49, the estimated annual number of new breast cancer cases in the United States was 60,610 in 2024
29
For women aged 50–59, the estimated annual number of new breast cancer cases in the United States was 88,720 in 2024
30
For women aged 60–69, the estimated annual number of new breast cancer cases in the United States was 83,870 in 2024
Interpretation
Epidemiology Interpretation
Although most breast cancer diagnoses occur later in life, with 47.7% of cases in SEER diagnosed at age 65 or older and a median age of 62 years, risk still rises steadily from about 0.06% at age 20 to 2.09% at age 50.
02 · Category
Age Distribution24 stats
01
28.6% of breast cancer cases are diagnosed in women aged 65 and older
02
30.3% of breast cancer cases are diagnosed in women aged 50–64
03
10.0% of breast cancer cases are diagnosed in women aged 40–49
04
7.5% of breast cancer cases are diagnosed in women aged 30–39
05
1.0% of breast cancer cases are diagnosed in women aged 20–29
06
0.1% of breast cancer cases are diagnosed in women aged under 20
07
In SEER, 63.7% of breast cancers are diagnosed after age 60
08
In SEER, 41.5% of breast cancers are diagnosed between ages 50 and 74
09
In SEER, 17% of breast cancers are diagnosed in women aged 50 or younger
10
The proportion of breast cancer cases diagnosed before age 50 is 16.0% in SEER
11
The proportion of breast cancer cases diagnosed before age 40 is 8.3% in SEER
12
For females aged 20–29, the SEER incidence rate is 13.0 per 100,000
13
For females aged 30–39, the SEER incidence rate is 74.5 per 100,000
14
For females aged 40–49, the SEER incidence rate is 162.9 per 100,000
15
For females aged 50–59, the SEER incidence rate is 229.6 per 100,000
16
For females aged 60–69, the SEER incidence rate is 230.1 per 100,000
17
For females aged 70–79, the SEER incidence rate is 197.2 per 100,000
18
For females aged 80+, the SEER incidence rate is 136.8 per 100,000
19
Breast cancer mortality rate for females aged 30–39 is 3.8 per 100,000
20
Breast cancer mortality rate for females aged 40–49 is 10.0 per 100,000
21
Breast cancer mortality rate for females aged 50–59 is 19.3 per 100,000
22
Breast cancer mortality rate for females aged 60–69 is 25.2 per 100,000
23
Breast cancer mortality rate for females aged 70–79 is 23.4 per 100,000
24
Breast cancer mortality rate for females aged 80+ is 17.0 per 100,000
Interpretation
Age Distribution Interpretation
Breast cancer is most commonly diagnosed in older women, with 28.6% of cases occurring at ages 65 and older and SEER showing 63.7% diagnosed after age 60, while mortality rates rise steeply from 3.8 per 100,000 at ages 30 to 39 to a peak of 25.2 per 100,000 at ages 60 to 69.
03 · Category
Biology & Risk17 stats
01
66% of breast cancer cases are estrogen receptor-positive
02
13% of breast cancers are HER2-positive (overexpressed or amplified)
03
72% of breast cancers are diagnosed as localized, regional, or distant with hormone receptor status affecting patterns by age
04
Breast cancer risk begins to rise around age 30 and increases markedly after age 40
05
The U.S. Preventive Services Task Force recommends screening mammography for women aged 40 to 74 (with screening interval and approach based on shared decision-making and evidence)
06
Women with a first-degree relative with breast cancer have about a 2-fold increased risk compared with women without such a family history
07
BRCA1 accounts for about 45% of hereditary breast cancers
08
BRCA2 accounts for about 35% of hereditary breast cancers
09
Women with a BRCA1 mutation have an estimated 65% risk of developing breast cancer by age 70
10
Women with a BRCA2 mutation have an estimated 45% risk of developing breast cancer by age 70
11
Risk-reducing salpingo-oophorectomy reduces breast cancer risk by about 50% in BRCA1/BRCA2 mutation carriers
12
A pooled analysis found that women aged 50 or older have higher absolute breast cancer risk when compared to younger age groups
13
Alcohol consumption increases breast cancer risk: each 10 g/day increase is associated with about a 7% increased risk
14
Postmenopausal obesity is associated with about a 3% increased risk of breast cancer per 1 unit increase in BMI
15
Current or recent use of combined estrogen-plus-progestin therapy is associated with an increased relative risk compared with never users
16
A meta-analysis reported that the relative risk of breast cancer is about 1.2 for each 5 kg/m² increase in BMI (postmenopausal women)
17
Physical activity reduces breast cancer risk: women who are the most active have about a 25% lower risk than those with the lowest activity
Interpretation
Biology & Risk Interpretation
Overall, breast cancer risk rises sharply with age and lifestyle, with screening recommended for women 40 to 74 and the strongest signals showing that risk increases markedly after 40 and can grow about 7% for every 10 g/day of alcohol while physical activity can cut risk by about 25%.
More related reading
04 · Category
Screening & Outcomes12 stats
01
About 14% of breast cancer cases are diagnosed at age 50 or younger
02
The U.S. Preventive Services Task Force recommends screening mammography every 2 years for women aged 50 to 74 (B recommendation, with grade dependent on interval)
03
Women aged 40 to 49 are recommended to make an individual decision about screening mammography (C recommendation)
04
For women aged 75 years and older, the USPSTF recommends that the decision to screen be individualized (recommendation statement addressing evidence)
05
The 5-year relative survival rate for localized breast cancer is 99%
06
The 5-year relative survival rate for regional breast cancer is 86%
07
The 5-year relative survival rate for distant breast cancer is 29%
08
The overall 5-year relative survival rate for breast cancer is 92%
09
The 10-year relative survival rate for breast cancer is 84%
10
Breast cancer screening detects cancers earlier, when localized to the breast, where 5-year survival is 99%
11
CDC estimates about 67.4% of women aged 40–74 years have ever had a mammogram within the past 2 years
12
CDC BRFSS 2022: 77.0% of women aged 50–74 years had a mammogram within the past 2 years
Interpretation
Screening & Outcomes Interpretation
About 77% of women aged 50–74 reported a mammogram within the past 2 years, and this matters because earlier detection is tied to much higher outcomes, with 5-year survival at 99% for localized breast cancer versus 29% when it has spread.
05 · Category
Costs & Care Use7 stats
01
The lifetime risk of breast cancer is 12.0% for women
02
The lifetime risk of dying from breast cancer is 2.8% for women
03
From 2010 to 2020, the number of breast cancer survivors in the United States increased from 2.9 million to 3.8 million
04
About 3.8 million women in the United States are breast cancer survivors (as of 2019)
05
A 2019 study estimated annual costs of breast cancer by age group, with higher costs in older age groups
06
In 2018, the average total cost of breast cancer treatment for women was $20,000–$30,000 in the first year depending on stage and therapy
07
The cost-effectiveness threshold commonly used in the US is about $100,000per quality-adjusted life year (QALY)
Interpretation
Costs & Care Use Interpretation
Between 2010 and 2020, the number of breast cancer survivors in the United States rose from 2.9 million to 3.8 million, while lifetime risk stands at 12.0% and annual treatment costs can be about $20,000 to $30,000 in the first year, underscoring both the growing survivor population and the substantial economic burden.
Reference
Cite This Report
This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.
APA
Stefan Wendt. (2026, February 13). Breast Cancer Age Statistics. Gitnux. https://gitnux.org/breast-cancer-age-statistics
MLA
Stefan Wendt. "Breast Cancer Age Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/breast-cancer-age-statistics.
Chicago
Stefan Wendt. 2026. "Breast Cancer Age Statistics." Gitnux. https://gitnux.org/breast-cancer-age-statistics.
Sources & references
19 datasets cited across this report · attribution is report-level
+7 additional datasets cited (not shown individually)